CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.
France-based CRYOPDP, a Cryoport company, has acquired Spain-based Polar Expres, a company that provides temperature-controlled shipments for biological and pharmaceutical materials worldwide.
According to a company press release, CRYOPDP has been actively acquiring companies with interesting new technologies, competencies, and similar principles to enhance its global delivery capacity. Polar Expres has an established presence in Europe’s cell & gene clinical research industry.
"The acquisition of Polar Expres will expand our coverage in Europe and enable us to provide end-to-end solutions to both global and local customers in Spain,” said Jerrell Shelton, CEO of Cryoport, in the press release. “Spain is a highly strategic and key area for pharma/biopharma clinical trials and a growing number of cell & gene activities.This tactical acquisition will provide strategic impact for CRYOPDP as requests for local, on-the-ground operations in Spain continues from many of our clients, as well as from potential new clients. With Polar Expres now operating as part of our growing CRYOPDP operations, we are confident this acquisition will provide us with additional growth in the EMEA region.”
Source: CRYOPDP
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.